Last reviewed · How we verify
Placebo Match to SH T00658ID — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Match to SH T00658ID (Placebo Match to SH T00658ID) — Bayer. This is a placebo control formulation designed to match the appearance and administration characteristics of an active investigational drug (SH T00658ID) in a Phase 3 clinical trial.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Match to SH T00658ID TARGET | Placebo Match to SH T00658ID | Bayer | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Match to SH T00658ID CI watch — RSS
- Placebo Match to SH T00658ID CI watch — Atom
- Placebo Match to SH T00658ID CI watch — JSON
- Placebo Match to SH T00658ID alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Match to SH T00658ID — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-match-to-sh-t00658id. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab